000			01955 a2200553 4500
005			20250516174442.0
264		0	_c20140908
008			201409s 0 0 eng d
022			_a1754-8411
024	7		_a10.1242/dmm.013219 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacob, John
245	0	0	_aValproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome. _h[electronic resource]
260			_bDisease models & mechanisms _cJan 2014
300			_a107-17 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAbnormalities, Drug-Induced _xgenetics
650	0	4	_aAnimals
650	0	4	_aAnticonvulsants _xchemistry
650	0	4	_aBasic Helix-Loop-Helix Transcription Factors _xgenetics
650	0	4	_aCell Differentiation
650	0	4	_aChild Development Disorders, Pervasive _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aEpigenesis, Genetic
650	0	4	_aGene Silencing
650	0	4	_aHistone Deacetylase 1 _xmetabolism
650	0	4	_aHomeostasis
650	0	4	_aNerve Tissue Proteins
650	0	4	_aNeurons _xmetabolism
650	0	4	_aReceptors, Notch _xmetabolism
650	0	4	_aSerotonin _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aTranscription Factors
650	0	4	_aTransgenes
650	0	4	_aValproic Acid _xadverse effects
650	0	4	_aZebrafish
650	0	4	_aZebrafish Proteins _xgenetics
700	1		_aRibes, Vanessa
700	1		_aMoore, Steven
700	1		_aConstable, Sean C
700	1		_aSasai, Noriaki
700	1		_aGerety, Sebastian S
700	1		_aMartin, Darren J
700	1		_aSergeant, Chris P
700	1		_aWilkinson, David G
700	1		_aBriscoe, James
773	0		_tDisease models & mechanisms _gvol. 7 _gno. 1 _gp. 107-17
856	4	0	_uhttps://doi.org/10.1242/dmm.013219 _zAvailable from publisher's website
999			_c23180313 _d23180313